No reduction in bleeding associated with bivalirudin use when compared to unfractionated heparin among patients with stable ischemic heart disease undergoing percutaneous coronary intervention.

Authors

Morgan Kellogg, Maine Medical Center
Yi-Ling Huang
Todd A. MacKenzie
Bina Ahmed
Matthew Watkins
Patrick Magnus
Jim Flynn
Peter N Ver Lee
David Malenka
Samip C. Vasaiwala, Maine Medical Center

Document Type

Article

Publication Date

3-2018

Institution/Department

Cardiology

Journal Title

Journal of the American College of Cardiology (JACC)

MeSH Headings

Coronary Artery Disease, Percutaneous Coronary Intervention, Peptide Fragments, Hirudins, Heparin, bivalirudin, Humans

Comments

Morgan Kellogg, MD- Fellow

First Page

A217

Last Page

A218

Recommended Citation

Kellogg, Morgan; Huang, Yi-Ling; MacKenzie, Todd A.; Ahmed, Bina; Watkins, Matthew; Magnus, Patrick; Flynn, Jim; Lee, Peter N Ver; Malenka, David; and Vasaiwala, Samip C., "No reduction in bleeding associated with bivalirudin use when compared to unfractionated heparin among patients with stable ischemic heart disease undergoing percutaneous coronary intervention." (2018). MaineHealth Maine Medical Center. 1124.
https://knowledgeconnection.mainehealth.org/mmc/1124